tissue microarray

NEW YORK (GenomeWeb News) – Nuclea Biotechnologies today announced the acquisition of a portfolio of six patents and applications related to tissue microarrays for an undisclosed amount.

Visiopharm and Integrated Systems Engineering have agreed to comarket their products to researchers using tissue microarrays.

By Justin Petrone
The National Institutes of Health is looking for a partner to commercialize a new tissue microarrayer that its inventor claims could cost one-tenth the price of similar instruments on the market.

The Karmanos Cancer Institute will use Definiens' Tissue Studio 2.0 digital pathology software to automate tissue section and microarray analysis.

Metamark disclosed last week in a filing with the US Securities and Exchange Commission that it raised about $22 million in a Series B round of financing. The company is targeting about $42 million in total.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.